会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • CHRONICALLY-IMPLANTABLE ACTIVE FIXATION MEDICAL ELECTRICAL LEADS AND RELATED METHODS FOR NON-FLUOROSCOPIC IMPLANTATION
    • 慢性植入式有源固定型医用电线及相关方法非手术植入
    • WO2008108901A1
    • 2008-09-12
    • PCT/US2007/089087
    • 2007-12-28
    • MEDTRONIC, INCMARKOWITZ, H. TobyCAMPBELL-MASSA, Sean T.SCANLON, DavidKRYGER, Michael A
    • MARKOWITZ, H. TobyCAMPBELL-MASSA, Sean T.SCANLON, DavidKRYGER, Michael A
    • A61B5/053A61N1/05
    • A61N1/0573A61B2034/2053A61N1/3627
    • Bio-impedance may be used for navigation systems to chronically implant pacing and defibrillation leads in the heart using a non-fluoroscopic position sensing unit (PSU), such as a modified LocaLisa® system from Medtronic Inc., which allows for variable frequency sampling of the position of electrode of a catheter. The PSU injects small AC signals via surface electrodes in three orthogonal axes, each on a slightly different frequency (e.g., near 30 KHz). Indwelling electrodes electrically connected to the PSU resolves the magnitude of induced voltage for each of the three frequencies, thus measuring voltage for each of the three axes. Voltages are divided by induced current to yield impedance in each axis for each electrode. Impedance is proportional to position within the body. Such a system requires that a conductive material, such as a retractable helical tip-electrode, be exposed during implantation. Since the tip is retracted during implantation, this disclosure provides a modified distal portion employing at least one aperture (or "window") for fluid exposure of the helix-electrode and a deployable internal sleeve for covering the aperture(s) when the helix-electrode is extended.
    • 生物阻抗可用于导航系统,以使用非荧光位置感测单元(PSU)长期地在心脏中植入起搏和除颤引线,例如来自Medtronic Inc.的经修改的LocaLisa系统,该系统允许对 导管电极的位置。 PSU通过三个正交轴中的表面电极注入小的AC信号,每个在稍微不同的频率(例如,接近30KHz)处。 电连接到PSU的留置电极解决三个频率中的每一个的感应电压的大小,从而测量三个轴中的每一个的电压。 电压被感应电流除以每个电极的每个轴线产生阻抗。 阻抗与体内的位置成比例。 这样的系统需要在植入期间露出诸如可伸缩螺旋尖端电极的导电材料。 由于尖端在植入期间缩回,本公开提供了一种修改的远侧部分,其采用至少一个用于螺旋电极的流体暴露的孔口(或“窗口”),以及可展开的内部套筒, 电极延长。
    • 2. 发明申请
    • FUSION PACING ENHANCEMENTS
    • 融合增强
    • WO2008097959A1
    • 2008-08-14
    • PCT/US2008/053037
    • 2008-02-05
    • MEDTRONIC, INC.BURNES, John E.KLECKNER, Karin J.MULLEN, Thomas J.
    • BURNES, John E.KLECKNER, Karin J.MULLEN, Thomas J.
    • A61N1/368
    • A61N1/3627A61N1/3682A61N1/3684
    • The disclosure provides methods and apparatus of left ventricular pacing including automated adjustment of a atrio-ventricular (AV) pacing delay interval and intrinsic AV nodal conduction testing. It includes - upon expiration or reset of a programmable AV Evaluation Interval (AVEI) - performing the following: temporarily increasing a paced AV interval and a sensed AV interval and testing for adequate AV conduction and measuring an intrinsic atrio-ventricular (PR) interval for a right ventricular (RV) chamber. Thus, in the event that the AV conduction test reveals a physiologically acceptable intrinsic PR interval then storing the physiologically acceptable PR interval in a memory structure (e.g., a median P-R from one or more cardiac cycles). In the event that the AV conduction test reveals an AV conduction block condition or if unacceptably long PR intervals are revealed then a pacing mode-switch to a bi-ventricular (Bi-V) pacing mode occurs and the magnitude of the AVEI is increased.
    • 本公开提供了左心室起搏的方法和装置,包括自动调节心房(AV)起搏延迟间隔和内部AV节点传导测试。 它包括 - 在可编程AV评估间隔(AVEI)到期或复位时 - 执行以下操作:临时增加节奏的AV间隔和感测到的AV间隔,并测试足够的AV传导并测量内在房室(PR)间隔 右心室(RV)室。 因此,在AV传导测试揭示生理上可接受的内在PR间隔的情况下,然后将生理上可接受的PR间期存储在存储器结构中(例如,来自一个或多个心动周期的中值P-R)。 在AV传导测试显示AV传导阻滞状态或者如果不能接受的长PR间隔被揭示的情况下,则起搏模式切换到双心室(Bi-V)起搏模式并且AVEI的幅度增加。
    • 6. 发明申请
    • METHOD OF CONTINUOUS CAPTURE VERIFICATION IN CARDIAC RESYNCHRONIZATION DEVICES
    • 心脏再生装置中连续检测验证方法
    • WO2007076177A1
    • 2007-07-05
    • PCT/US2006/060812
    • 2006-11-12
    • MEDTRONIC, INC.BUSACKER, James W.SHELDON, Todd J.
    • BUSACKER, James W.SHELDON, Todd J.
    • A61N1/00
    • A61N1/3627A61N1/3684A61N1/371
    • In bi-ventricular pacing devices (including CRT devices) analysis of myocardial electrogram signals in one ventricle (e.g., a left ventricle, or "LV") can be used to infer capture or loss-of-capture (LOC) of an earlier stimulus pulse in the same ventricle, on a continuous (every pacing cycle), triggered, aperiodic and/or periodic basis. Rather than using an evoked-response principle as has been the basis of capture detection in prior art and other systems, a principle employed via the present invention uses evidence of inter-ventricular conduction (i.e., from the opposite chamber) and/or atrio-ventricular conduction as evidence of LOC, since a non-capturing pacing stimulus provided to a first chamber will allow the myocardial tissue of the first chamber to remain non-refractory and thus inter-ventricular and atrio-ventricular wavefront propagation and conduction can commence and be detected thereby revealing whether LOC has occurred.
    • 在双心室起搏装置(包括CRT装置)中,可以使用一个心室(例如,左心室或“LV”)分析心肌电图信号来推断早期刺激的捕获或丢失(LOC) 脉冲在同一个心室,连续(每个起搏周期),触发,非周期和/或周期基础。 不是使用诱发反应原理作为现有技术和其他系统中的捕获检测的基础,通过本发明采用的原理使用室间传导(即,从相对的室)和/或心室传导的证据, 心室传导作为LOC的证据,因为提供给第一腔室的非捕获起搏刺激将允许第一腔室的心肌组织保持不耐受,因此可以开始心室间和心房内波前传播和传导 从而揭示LOC是否发生。
    • 9. 发明申请
    • SOFTWARE CONFIGURABLE MEDICAL DEVICE PLATFORM
    • 软件可配置医疗设备平台
    • WO2006044406A1
    • 2006-04-27
    • PCT/US2005/036562
    • 2005-10-13
    • MEDTRONIC, INC.DENO, D. CurtisWILKINSON, Jeffrey, D.STROEBEL, John, C.
    • DENO, D. CurtisWILKINSON, Jeffrey, D.STROEBEL, John, C.
    • A61N1/365
    • A61N1/3625A61N1/365A61N1/3956
    • A new design platform for implantable and external medical devices such as pacemakers, defibrillators, neurostimulators, heart monitors, etc. is provided. A real-time, highly flexible system of software and hardware modules enables both phototypes and products to respond to patient and customer needs with greater design and manufacturing efficiency. Certain embodiments integrate a general-purpose processor with interface circuitry to provide a standard platform for implement. The invention relates to medical devices such as pacemakers, pulse generators, cardioverter-defibrillators and the like and more particularly relates to modular and reconfigurable medical system platforms and methods of designing, testing, controlling and implementing diverse therapies, diagnostics, physiologic sensors and related instrumentation using said medical system platforms. Methods, systems and devices provide a new design platform for implantable and external medical devices such as pacemakers, defibrillators, neurostimulators, heart monitors, etc. A real-time, highly flexible system of software and hardware modules enables both prototypes and products to respond.
    • 提供了一种用于植入式和外部医疗设备(如起搏器,除颤器,神经刺激器,心脏监护仪等)的新设计平台。 实时,高度灵活的软件和硬件模块系统使照片和产品能够以更高的设计和制造效率满足患者和客户的需求。 某些实施例将通用处理器与接口电路集成以提供用于实现的标准平台。 本发明涉及诸如起搏器,脉冲发生器,心律转复除颤器等的医疗装置,更具体地涉及模块化和可重构医疗系统平台以及设计,测试,控制和实施多种疗法,诊断,生理传感器和相关仪器的方法 使用医疗系统平台。 方法,系统和设备为植入式和外部医疗设备(如起搏器,除颤器,神经刺激器,心脏监测器等)提供了一个新的设计平台。实时,高度灵活的软件和硬件模块系统使原型和产品都能够响应。
    • 10. 发明申请
    • ION SENSOR FOR LONG TERM USE IN COMPLEX MEDIUM
    • 离子传感器长时间使用复合介质
    • WO2006014758A2
    • 2006-02-09
    • PCT/US2005/025775
    • 2005-07-20
    • MEDTRONIC, INC.QINGSHAN, Ye
    • QINGSHAN, Ye
    • G01N27/333A61B5/00
    • A61B5/14542A61B5/14546A61B5/1473
    • Devices and methods for measuring a target ion concentration uses an electrode pair. The pair includes a working electrode and a reference electrode. The working and reference electrodes are ion-selective electrodes (ISEs). The reference ISE can include a sodium ISE. The ISE pair interacts with body fluids where a target ion concentration changes more than sodium ion concentration over time. Some ISE membranes of a pair vary essentially only in the ionophore. An ISE pair can determine the ratio of a target ion concentration to sodium ion concentration in vivo. Periodic measurement of sodium concentration in drawn blood can be used to calibrate an ISE pair and provide target ion concentration as an output. Or, a potassium/sodium ISE pair beneficially monitors potassium concentration changes over time in heart- or kidney-failure patients. Then, manual or automatic titration of a diuretic material can be implemented to maintain a desired potassium concentration.
    • 用于测量目标离子浓度的装置和方法使用电极对。 该对包括工作电极和参考电极。 工作电极和参比电极是离子选择电极(ISE)。 参考ISE可以包括钠ISE。 ISE对与体液相互作用,其中目标离子浓度随时间而变化超过钠离子浓度。 一对一对ISE膜基本上仅在离子载体中变化。 ISE对可以确定目标离子浓度与体内钠离子浓度之比。 抽取血液中钠浓度的定期测定可用于校准ISE对,并提供目标离子浓度作为输出。 或者,在心脏或肾衰竭患者中,钾/钠ISE对有效地监测钾浓度随时间的变化。 然后,可以实施手动或自动滴定利尿剂材料以维持所需的钾浓度。